目的分析良性前列腺增生(benign prostatic hyperplasia,BPH)患者膀胱内前列腺(intravesical prostatic protrusion,IPP)超声学测量与最大尿流率(the maximum uroflow rate,Qmax)之间的相关性,探讨三维超声在良性前列腺增生诊断及治疗...目的分析良性前列腺增生(benign prostatic hyperplasia,BPH)患者膀胱内前列腺(intravesical prostatic protrusion,IPP)超声学测量与最大尿流率(the maximum uroflow rate,Qmax)之间的相关性,探讨三维超声在良性前列腺增生诊断及治疗中的应用价值。方法对30例伴有膀胱内前列腺的良性前列腺增生患者行经腹二维及三维超声检查,检测前列腺总体积(total prostate volume,TPV)、残余尿量(postvoid residual urine volume,PVR)、IPP体积及长度、IPP体积与前列腺总体积的比值(the ratio between the volume of IPP and TPV,IPPR),分别与Qmax进行相关性分析。结果年龄、PVR、TPV、IPP体积、IPP长度及IPPR与Qmax之间均存在相关性(P<0.05)。结论应用计算机辅助虚拟脏器分析(virtual organ computer-aid analysis,VOCAL)技术准确测量BPH患者前列腺形态学参数,对评估BPH程度有较好的应用价值,可作为尿动力学检查外,评价膀胱出口梗阻(bladder outlet obstruction,BOO)程度的补充手段,并可为临床治疗提供更丰富的信息,指导临床治疗。展开更多
<strong>Background:</strong> Ultrasound is the main method of exploring the prostate. In benign prostatic hyperplasia (BPH), it provides important morphological information and assesses its impact, helping...<strong>Background:</strong> Ultrasound is the main method of exploring the prostate. In benign prostatic hyperplasia (BPH), it provides important morphological information and assesses its impact, helping to guide the treatment. <strong>Objective:</strong> To compare intravesical prostatic protrusion (IPP) and middle lobe volume by ultrasound in BPH. <strong>Method:</strong> This was a single center prospective, descriptive and analytical study, over a period of 6 months, including 95 patients, undergoing prostatic trans-abdominal ultrasound. Patients were selected by a single urologist for clinical suspicion of benign prostatic hypertrophy. The ultrasound examination was done by a single senior radiologist. <strong>Results:</strong> The mean age of the patients was 66.63 ± 11.55 years with ranges from 38 to 98 years. The prevalence of BPH was 76.84%. The rate of patient with middle lobe protrusion was 48.42%. The mean middle lobe volume was 11.29 ± 12.90 ml. More than half of the patients (50.91%) had an IPP stage 3 of. The mean bladder wall thickness was 6.08 ± 2.58 mm, with 50.53% being pathological. The post-voiding residue (PVR) was significant in 38.75% of patients. Renal repercussions were present in 17.89%. The correlation analysis did not note a statistical link between prostate volume and quality of life score (<em>p</em> > 0.05). There was a statistically significant correlation between IPP values and quality of life score (<em>p</em> = 00461), IPSS score (<em>p</em> = 0.0424) and PVR (<em>p</em> = 0.0395). For middle lobe volume, there was a correlation with PVR (<em>p</em> = 0.0018). There was no correlation with clinical impact (quality of life score and IPSS score). <strong>Conclusion:</strong> The IPP appears to be an easy element to measure and better than the volume of the prostate and the middle lobe in assessing the impact of BPH.展开更多
文摘目的分析良性前列腺增生(benign prostatic hyperplasia,BPH)患者膀胱内前列腺(intravesical prostatic protrusion,IPP)超声学测量与最大尿流率(the maximum uroflow rate,Qmax)之间的相关性,探讨三维超声在良性前列腺增生诊断及治疗中的应用价值。方法对30例伴有膀胱内前列腺的良性前列腺增生患者行经腹二维及三维超声检查,检测前列腺总体积(total prostate volume,TPV)、残余尿量(postvoid residual urine volume,PVR)、IPP体积及长度、IPP体积与前列腺总体积的比值(the ratio between the volume of IPP and TPV,IPPR),分别与Qmax进行相关性分析。结果年龄、PVR、TPV、IPP体积、IPP长度及IPPR与Qmax之间均存在相关性(P<0.05)。结论应用计算机辅助虚拟脏器分析(virtual organ computer-aid analysis,VOCAL)技术准确测量BPH患者前列腺形态学参数,对评估BPH程度有较好的应用价值,可作为尿动力学检查外,评价膀胱出口梗阻(bladder outlet obstruction,BOO)程度的补充手段,并可为临床治疗提供更丰富的信息,指导临床治疗。
文摘<strong>Background:</strong> Ultrasound is the main method of exploring the prostate. In benign prostatic hyperplasia (BPH), it provides important morphological information and assesses its impact, helping to guide the treatment. <strong>Objective:</strong> To compare intravesical prostatic protrusion (IPP) and middle lobe volume by ultrasound in BPH. <strong>Method:</strong> This was a single center prospective, descriptive and analytical study, over a period of 6 months, including 95 patients, undergoing prostatic trans-abdominal ultrasound. Patients were selected by a single urologist for clinical suspicion of benign prostatic hypertrophy. The ultrasound examination was done by a single senior radiologist. <strong>Results:</strong> The mean age of the patients was 66.63 ± 11.55 years with ranges from 38 to 98 years. The prevalence of BPH was 76.84%. The rate of patient with middle lobe protrusion was 48.42%. The mean middle lobe volume was 11.29 ± 12.90 ml. More than half of the patients (50.91%) had an IPP stage 3 of. The mean bladder wall thickness was 6.08 ± 2.58 mm, with 50.53% being pathological. The post-voiding residue (PVR) was significant in 38.75% of patients. Renal repercussions were present in 17.89%. The correlation analysis did not note a statistical link between prostate volume and quality of life score (<em>p</em> > 0.05). There was a statistically significant correlation between IPP values and quality of life score (<em>p</em> = 00461), IPSS score (<em>p</em> = 0.0424) and PVR (<em>p</em> = 0.0395). For middle lobe volume, there was a correlation with PVR (<em>p</em> = 0.0018). There was no correlation with clinical impact (quality of life score and IPSS score). <strong>Conclusion:</strong> The IPP appears to be an easy element to measure and better than the volume of the prostate and the middle lobe in assessing the impact of BPH.
